Madilyn Gaydos, B.S.

RESEARCH SUMMARY

Madilyn graduated with High Honors from the University of Michigan in 2024, earning a B.S. in Biochemistry with a minor in Science, Technology, and Society. Her academic journey included pioneering research investigating neutrophil extracellular traps as a potential therapeutic target for combating triple-negative breast cancer.  Madilyn currently continues to follow her passion for immunology research and serves as a Postbaccalaureate Fellow in Dr. Mitchell Ho’s lab at the National Cancer Institute, concentrating on developing a dual-targeting antibody T cell receptor aimed at GPC2 and B7-H3 (CD276) for potential therapeutic applications in Neuroblastoma treatment.